Levofloxacin, Amoxicillin, and Omeprazole as First-line Triple Therapy for Helicobacter pylori Eradication-Reference-Cited by-同舟云学术

Levofloxacin, Amoxicillin, and Omeprazole as First-line Triple Therapy for Helicobacter pylori Eradication

Published:2009-04 Issue:4 Volume:43 Page:384-385
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Gisbert Javier P.,Bermejo Miguel Fernández,Infante Javier Molina,Gallardo Belén Pérez,Bermejo Ana-Beatriz Prieto,Rodríguez José-María Mateos,Andrés Pilar Robledo,García Guadalupe González

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference12 articles.

1. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report;Malfertheiner;Gut,2007

2. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure;Gisbert;Aliment Pharmacol Ther,2006

3. H. pylori antibiotic resistance: prevalence, importance, and advances in testing;Megraud;Gut,2004

4. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity;Antos;Helicobacter,2006

5. A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses;Gatta;Aliment Pharmacol Ther,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Reevaluation of the Efficacy of First Line Regimen for Helicobacter pylori

;Clinical and Experimental Gastroenterology;2020-01

2. The comparison of levofloxacin- and clarithromycin-based bismuth quadruple therapy regimens in Helicobacter pylori eradication;Journal of Research in Pharmacy Practice;2020

3. Helicobacter pylori treatment: New perspectives using current experience;Journal of Global Antimicrobial Resistance;2017-03

4. Fluoroquinolone-based protocols for eradication of Helicobacter pylori;WORLD J GASTROENTERO;2014

5. Levofloxacin and proton pump inhibitor-based triple therapy versus standard triple first-line therapy forHelicobacter pylorieradication;Pharmacoepidemiology and Drug Safety;2014-02-21